Works from 2023
A Case Report of Amiodarone-Induced Thyrotoxicosis Requiring Plasmapheresis as a Bridge to Total Thyroidectomy, Tina Moazezi and Chung-Kay Koh (Poster)
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization, Nicola A. Hanania, Russell A. Settipane, Samir Khoury, et al. (Article)
Asthma morbidity measures across Black ethnic subgroups, Leah Ishmael, Juan Carlos Cardet, Michael Foggs, et al. (Abstract)
A Unique Case of Immunotherapy Related Autoimmune Complications, Hardeep S. Ahdi, Edward Nabrinsky, and Sufyan Abdulmujeeb (Poster)
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19, Ziad Bakouny, Chris Labaki, Punita Grover, et al. (Article)
Long-term efficacy and safety of Upadacitinib in patients with rheumatoid arthritis: Final results from the BALANCE-EXTEND Open-Label Extension Study, Alan Kivitz, Alvin F. Wells, Juan I. Vargas, et al. (Article)
Proposed solutions by the American College of Allergy, Asthma, and Immunology and advocacy experts to address racial disparities in atopic dermatitis and food allergy, Mark Corbett, Abby Allen, Nichole Bobo, et al. (Article)
Real-world outcomes with immuno-oncology therapies in advanced melanoma: Final results of the OPTIMIzE registry study, John M. Kirkwood, Lisa A. Kottschade, Robert R. McWilliams, et al. (Article)
Works from 2022
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients, Alvin F. Wells, Christopher J Edwards, Alan J Kivitz, et al. (Article)
A review of the abscopal effect in the era of immunotherapy, Edward Nabrinsky, Jason Macklis, and Jacob Bitran (Article)
Baseline disease activity predicts achievement of cDAPSA treatment targets with apremilast: Phase 3 results in DMARD-naive patients with psoriatic arthritis, Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, et al. (Article)
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease, Song Lu, John V. White, Ifeyinwa Nwaneshiudu, et al. (Article)
Lymphadenopathy, Sarah Burroughs and Evan Kang (Book Chapter)
Optimizing asthma management: Role of long-acting muscarinic antagonists, Thomas B. Casale, Michael B. Foggs, and Ronald C. Balkissoon (Article)
Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: When will we achieve parity?, Jagannadha Avasarala, Phenu Zachariah, and Breck Turner (Article)
The role of physician advocacy in achieving health equity: Where is the allergist-immunologist?, Margee Louisias, Roselyn Hicks, Samantha Jacobs, et al. (Article)
Works from 2021
Efficacy of long-term treatment with once-daily baricitinib 2 mg in patients with active rheumatoid arthritis: Post hoc analysis of two 24-week, phase III, randomized, controlled studies and one long-term extension study, Alvin F. Wells, Bochao Jia, Li Xie, et al. (Article)
Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: A work group report of the AAAAI committee on the underserved., Carla M Davis, Andrea J Apter, Adrian Casillas, et al. (Article)
Leveraging Human Genetic Variation to Uncover the Molecular Basis of T Cell Selection and Autoimmunity, Caroline Kaiser, Narutoshi Hibino, Emily Pena, and Andrew Koh (Poster)
Myasthenia gravis induced or exacerbated by immune checkpoint inhibitors: a rising concern, Behnam Hajihossainlou, Alisa Vasileva, Sukesh Manthri, et al. (Article)
Works from 2020
How does stellate ganglion block alleviate immunologically-linked disorders?, Eugene Lipov, Vicko Gluncic, Ivan K Lukić, et al. (Article)
Reasons for hospitalization and in-hospital mortality in adult systemic lupus erythematosus, Augustine M Manadan, Soumyasri Kambhatla, Estefania Gauto-Mariotti, et al. (Article)
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY, Vibeke Strand, Namita Tundia, Alvin Wells, et al. (Article)
Work Group Report: COVID-19: Unmasking Telemedicine, Nathan Hare, Priya Bansal, Sakina S Bajowala, et al. (Article)
Works from 2019
Assessment of citations of the retracted article by Wakefield et al with fraudulent claims of an association between vaccination and autism, Elizabeth M. Suelzer, Jennifer Deal, Karen L. Hanus, et al. (Article)
Works from 2016
Differential effects of alternative glycoforms of IgG on human monocytes and macrophages: sialylated IgG induces novel expression signatures of cell surface markers, cytokines, and chemokines, Eric D. Bruder, John O. Richards, Karen M. Michel, et al. (Article)
Works from 2006
A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4, Dhanalakshmi Chinnasamy, Matt Tector, Nachimuthu Chinnasamy, et al. (Article)
Effect of targeting BTLA-HVEM co-inhibitory pathway in partial MHC-mismatched cardiac grafts, V Vadivel, J Yang, V K. Vanguri, et al. (Abstract)
Works from 2005
Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population, Cai Lei, Zhang Dongqing, Shi Yeqing, et al. (Article)
CTLA-4 is important in maintaining long-term survival of cardiac allografts, Anil Chandraker, Volkert Huurman, Karen Hallett, et al. (Article)
Expression of FOX-P3, GATA-3, and GITR during tolerance and breaking of tolerance: Abstract #221., Willem-jan Flu, Anna-Maria Wagga, Volkert Huurman, et al. (Abstract)
Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination, Nachimuthu Chinnasamy, Martin Oaks, J S. Treisman, et al. (Article)
Works from 2003
Alloimmune induction of endothelial cell-derived interferon-gamma-inducible chemokines, Raghavanpillai Raju, Angela Malloy, Tara Shah, et al. (Article)
A novel monoclonal anti-rat CTLA4 antibody abrogates longterm cardiac allograft survival induced by anti-CD28/CSA, Xueli Yuan, Volkert Huurman, Alan D. Salama, et al. (Abstract)
Works from 2000
A native soluble form of CTLA-4, Martin Oaks, Karen Hallett, R T Penwell, et al. (Article)
Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease, Martin Oaks and Karen M. Hallett (Article)
Works from 1994
Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy, Martin K. Oaks, J P Hanson, and D P O'Malley (Article)
Works from 1992
The effect of cimetidine on lymphocyte subpopulations in vivo in experimental mice, A Kumar, Martin K. Oaks, and K J Kelly (Article)